Nidan Laboratories IPO vs Suyog Gurbaxani Funicular IPO

Comparison between Nidan Laboratories IPO and Suyog Gurbaxani Funicular IPO.

IPO Details

Nidan Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Suyog Gurbaxani Funicular IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Nidan Laboratories IPO is up to ₹47.50 Cr whereas the issue size of the Suyog Gurbaxani Funicular IPO is up to ₹28.00 Cr. The final issue price of Nidan Laboratories IPO is ₹125.00 per share and of Suyog Gurbaxani Funicular IPO is ₹45.00 per share.

 Nidan Laboratories IPOSuyog Gurbaxani Funicular IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹125.00 per share₹45.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1000 shares3000 shares
Fresh Issue Size38,00,000 shares11,67,000 shares
Fresh Issue Size (Amount)up to ₹47.50 Crup to ₹5.25 Cr
OFS Issue Size0 shares50,55,000 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹22.75 Cr
Issue Size Total38,00,000 shares62,22,000 shares
Issue Size Total (Amount)up to ₹47.50 Crup to ₹28.00 Cr

IPO Timetable

Nidan Laboratories IPO opens on Oct 28, 2021, while Suyog Gurbaxani Funicular IPO opens on Nov 01, 2021. The closing date of Nidan Laboratories IPO and Suyog Gurbaxani Funicular IPO is Nov 02, 2021, and Nov 08, 2021, respectively.

 Nidan Laboratories IPOSuyog Gurbaxani Funicular IPO
Issue OpenOct 28, 2021Nov 01, 2021
Issue CloseNov 02, 2021Nov 08, 2021
Basis Of Allotment (Tentative)Nov 09, 2021Nov 11, 2021
Initiation of Refunds (Tentative)Nov 10, 2021Nov 12, 2021
Credit of Share (Tentative)Nov 11, 2021Nov 15, 2021
Listing date (Tentative)Nov 12, 2021Nov 16, 2021

Financials & KPIs

Nidan Laboratories IPO P/E ratio is , as compared to Suyog Gurbaxani Funicular IPO P/E ratio of .

 Nidan Laboratories IPOSuyog Gurbaxani Funicular IPO
Financials

Company Financials (Restated)

Period Ended30 Jun 202131 Mar 202131 Mar 202031 Mar 2019
Assets54.3352.4445.2143.06
Total Income7.8521.8522.1920.97
Profit After Tax1.092.300.710.22
NET Worth14.4213.3311.0310.31
Total Borrowing37.0936.5034.3532.17
Amount in ₹ Crore

Company Financials (Restated)

Period Ended30 Jun 202131 Mar 202131 Mar 202031 Mar 2019
Assets84.3186.2088.7194.11
Total Income0.004.4813.197.91
Profit After Tax-2.32-7.93-1.88-3.48
NET Worth7.746.9914.9216.80
Reserves and Surplus-15.62-13.30-5.37-3.48
Total Borrowing72.4574.7767.8771.27
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)99.99%90.57%
Promoter Shareholding (Post-Issue)71.22%64.78%
Market Cap₹173.75 Cr.₹111.88 Cr.

Shares Offered

In the Nidan Laboratories IPO Retail Individual Investors (RII) are offered 19,00,000 shares while in Suyog Gurbaxani Funicular IPO retail investors are offered 19,00,000 shares. Qualified Institutional Buyers (QIB) are offered in Nidan Laboratories IPO and 0 shares in Suyog Gurbaxani Funicular IPO.

 Nidan Laboratories IPOSuyog Gurbaxani Funicular IPO
Anchor Investor Reservation0 shares
Market Maker Reservation2,00,000 shares3,33,000 shares
QIB0 shares
NII19,00,000 shares31,11,000 shares
RII19,00,000 shares31,11,000 shares
Employee0 shares
Total38,00,000 shares62,22,000 shares

Bids Received (Subscription)

Nidan Laboratories IPO subscribed 1.80x in total, whereas Suyog Gurbaxani Funicular IPO subscribed 1.27x.

Compare with others

Compare: